Technology, Big Data Analytics
and Artificial Intelligence
MindBio has taken a big data approach to accumulating
data in human clinical trials. The Company has made several
major discoveries and developments in the process.
Emerging Predictive Health Technologies
MindBio has amassed a significant amount of data from human clinical trials that it is using to create precision approaches to medicine development. The Company recently acquired Life AI Corp, a life sciences focused company that uses AI and machine learning techniques to create predictive technologies to enhance health and wellness at scale.
Our Technology Brands
A world’s first voice activated and AI powered estimator of blood alcohol concentration over a smartphone.
Life AI Corp, a life sciences focused company that uses AI and machine learning techniques to create predictive technologies to enhance health and wellness at scale.
MICRODOSING (MB22001), a very small dose of a psychedelic medicine is potentially a globally scalable and affordable solution to using psychedelic medicines to treat mental health conditions in medical practice. Our Phase 1 and Phase 2 take-home clinical trials have shown the medicine in small doses can be taken safely and effectively by patients out in the community. Patients can take MB22001 at home and then get on with their day with minimal disruption.